ARIXA PHARMACEUTICALS
Arixa Pharmaceuticals is developing oral antibiotics for resistant Gram-negative infections, an urgent need. Their lead program is an oral prodrug of Avibactam, a broad spectrum beta-lactamase inhibitor recently approved by FDA. They have addressed and solved the medicinal chemistry issues which complicate the prodrugging of this class of compounds, and expect to receive broad composition of matter patent protection.
ARIXA PHARMACEUTICALS
Industry:
Emergency Medicine Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.arixapharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
13 M USD
Technology used in webpage:
SPF Oracle Cloud
Similar Organizations
Apic Bio
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Emedgene
Emedgene provides data-driven AI solutions for genomic diagnostics and discovery at scale.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Venatorx Pharmaceuticals
Venatorx Pharmaceuticals develops anti-infectives to treat multi-drug-resistant bacterial infections and viral infections.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.arixapharma.com
- Host name: 147.154.27.36
- IP address: 147.154.27.36
- Location: Seattle United States
- Latitude: 47.6109
- Longitude: -122.3303
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98101
More informations about "Arixa Pharmaceuticals"
Arixa Pharmaceuticals - Crunchbase Company Profile
Contact Email [email protected] Arixa Pharmaceuticals is developing oral antibiotics for resistant Gram-negative infections, an urgent need. Their lead …See details»
Arixa Pharmaceuticals - PitchBook
Arixa Pharmaceuticals General Information Description. Producer of oral antibiotics intended for resistant Gram-negative infections. The company created a series of safe oral prodrugs of avibactam, a β-lactamase inhibitor approved …See details»
Arixa Pharmaceuticals - Overview, News & Similar companies
Oct 22, 2020 www.arixapharma.com. Revenue <$5 Million. Industry Manufacturing General Manufacturing . Recent News & Media. Could Arixa Pharmaceuticals’ Lead Product Pave the …See details»
Arixa Pharmaceuticals Announces Acquisition by Pfizer’s
Oct 22, 2020 PALO ALTO, Calif.--(BUSINESS WIRE)-- Arixa Pharmaceuticals™, Inc., a company dedicated to developing next-generation oral antibiotics for drug-resistant Gram …See details»
Arixa Pharmaceuticals - Craft
Arixa Pharmaceuticals is a company that develops oral antibiotics for resistant gram-negative infections. It applies prodrug chemistry to existing intravenous-only antimicrobial agents to …See details»
Arixa Pharmaceuticals Inc - Company Profile and News
Company profile page for Arixa Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Arixa Pharmaceuticals, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore Arixa Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, and 1 literature, Disease Domain ...See details»
Pfizer will buy antibiotic maker Arixa - Chemical & Engineering News
Oct 31, 2020 Pfizer has agreed to buy Arixa Pharmaceuticals, a California-based company developing oral antibiotics for drug-resistant infections. Pfizer will advance Arixa’s lead …See details»
Arixa Pharmaceuticals - Products, Competitors, Financials, …
Arixa Pharmaceuticals is developing oral antibiotics for resistant gram-negative infections. Use the CB Insights Platform to explore Arixa Pharmaceuticals's full profile.See details»
Pfizer Expands Antibacterial Portfolio by Acquiring …
Oct 28, 2020 By Ruchi Jhonsa, Ph.D. On 22nd October, Pfizer’s Hospital Business announced the acquisition of Arixa Pharmaceuticals, a company dedicated to developing next-generation antibiotics for drug-resistant gram …See details»
Arixa - VentureRadar
Website: https://www.arixapharma.com/ Arixa Pharmaceuticals is developing oral antibiotics for resistant Gram-negative infections, an urgent need.See details»
Arixa Pharmaceuticals Announces Acquisition by Pfizer
Oct 22, 2020 PALO ALTO, Calif.--(BUSINESS WIRE)--Arixa Pharmaceuticals™, Inc., a company dedicated to developing next-generation oral antibiotics for drug-resistant Gram …See details»
Arixa Pharmaceuticals Announces Acquisition by Pfizer’s Hospital ...
Oct 22, 2020 “We are proud to have created and developed an important new drug candidate in a highly capital efficient manner, and believe Pfizer is the perfect company to take ARX-1796 …See details»
Pfizer acquires Arixa Pharmaceuticals - 2020-10-22 - Crunchbase
Oct 22, 2020 Acquired Organization: Arixa Pharmaceuticals Arixa Pharmaceuticals is a developing oral antibiotics for drug-resistant Gram-negative infections. Acquiring Organization: …See details»
Arixa | VentureRadar
Similar Companies: Sun BioPharma USA Privately Held Sun BioPharma is developing small-molecule pharmaceuticals consisting of novel polyamine analogues and metal chelators, and …See details»
Pfizer snaps up antibiotics maker Arixa and its oral Avycaz follow-up
Oct 22, 2020 This summer, Pfizer teamed up with other Big Pharmas on a $1 billion fund to bolster struggling antibiotics makers. Now, the company is adding a new antibiotic candidate …See details»
Arixa Pharmaceuticals Completes $8 Million Seed Funding to …
May 1, 2018 PALO ALTO, Calif.--(BUSINESS WIRE)-- Arixa Pharmaceuticals™, Inc., a company dedicated to developing oral antibiotics for drug-resistant Gram-negative infections, …See details»
Arixa Pharmaceuticals, Inc. (Arixa Pharmaceuticals, Inc.) - 药物管 …
了解Arixa Pharmaceuticals, Inc. (Arixa Pharmaceuticals, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 2篇新闻，疾病领域:感染，技术平台:小分子化药，药物:ARX …See details»
Pfizer will buy antibiotic maker Arixa | C&EN Global Enterprise
Nov 2, 2020 Pfizer has agreed to buy Arixa Pharmaceuticals, a California-based company developing oral antibiotics for drug-resistant infections. Pfizer will advance Arixa’s lead …See details»
Arixa Pharmaceuticals - Contacts, Employees, Board Members, …
Arixa Pharmaceuticals is a developing oral antibiotics for drug-resistant Gram-negative infections.See details»